Published in J Clin Invest on March 01, 2004
Mitochondrial glutathione, a key survival antioxidant. Antioxid Redox Signal (2009) 2.28
S-adenosylmethionine in liver health, injury, and cancer. Physiol Rev (2012) 1.82
Cytolytic T cells induce ceramide-rich platforms in target cell membranes to initiate graft-versus-host disease. Blood (2009) 1.67
Liquid chromatography-mass spectrometry-based parallel metabolic profiling of human and mouse model serum reveals putative biomarkers associated with the progression of nonalcoholic fatty liver disease. J Proteome Res (2010) 1.29
Acidic sphingomyelinase controls hepatic stellate cell activation and in vivo liver fibrogenesis. Am J Pathol (2010) 1.24
Reactive oxygen species mediate liver injury through parenchymal nuclear factor-kappaB inactivation in prolonged ischemia/reperfusion. Am J Pathol (2009) 1.15
Redox control of liver function in health and disease. Antioxid Redox Signal (2010) 1.12
Mitochondrial glutathione: features, regulation and role in disease. Biochim Biophys Acta (2012) 1.11
Cathepsin B overexpression due to acid sphingomyelinase ablation promotes liver fibrosis in Niemann-Pick disease. J Biol Chem (2011) 1.07
Glycosphingolipids and mitochondria: role in apoptosis and disease. Glycoconj J (2004) 0.98
Metabolomic profiling to identify predictors of response to vitamin E for non-alcoholic steatohepatitis (NASH). PLoS One (2012) 0.96
Membrane TNF-alpha-activated programmed necrosis is mediated by Ceramide-induced reactive oxygen species. J Mol Signal (2013) 0.92
Copper: toxicological relevance and mechanisms. Arch Toxicol (2014) 0.90
ASMase regulates autophagy and lysosomal membrane permeabilization and its inhibition prevents early stage non-alcoholic steatohepatitis. J Hepatol (2014) 0.86
Mitochondrial cholesterol accumulation in alcoholic liver disease: Role of ASMase and endoplasmic reticulum stress. Redox Biol (2014) 0.80
Glycosphingolipids and cell death: one aim, many ways. Apoptosis (2015) 0.78
Stable Isotope Dilution Assays for Clinical Analyses of Folates and Other One-Carbon Metabolites: Application to Folate-Deficiency Studies. PLoS One (2016) 0.76
Acid Sphingomyelinase Inhibition Prevents Development of Sepsis Sequelae in the Murine Liver. Sci Rep (2017) 0.75
Bafilomycins: a class of inhibitors of membrane ATPases from microorganisms, animal cells, and plant cells. Proc Natl Acad Sci U S A (1988) 10.77
AU binding proteins recruit the exosome to degrade ARE-containing mRNAs. Cell (2001) 7.79
Lethal toxicity of lipopolysaccharide and tumor necrosis factor in normal and D-galactosamine-treated mice. J Exp Med (1987) 4.63
Cathepsin B contributes to TNF-alpha-mediated hepatocyte apoptosis by promoting mitochondrial release of cytochrome c. J Clin Invest (2000) 3.58
Methionine metabolism in mammals. J Nutr Biochem (1990) 3.06
Ceramide in the eukaryotic stress response. Trends Cell Biol (2000) 2.98
Oocyte apoptosis is suppressed by disruption of the acid sphingomyelinase gene or by sphingosine-1-phosphate therapy. Nat Med (2000) 2.96
Methionine adenosyltransferase 1A knockout mice are predisposed to liver injury and exhibit increased expression of genes involved in proliferation. Proc Natl Acad Sci U S A (2001) 2.93
Mannose 6-phosphate receptors and lysosomal enzyme targeting. J Biol Chem (1989) 2.77
Functional dichotomy of neutral and acidic sphingomyelinases in tumor necrosis factor signaling. Cell (1994) 2.68
Regulation of ceramide production and apoptosis. Annu Rev Physiol (1998) 2.54
Sphingolipid metabolism and cell growth regulation. FASEB J (1996) 2.53
Enzymes of sphingolipid metabolism: from modular to integrative signaling. Biochemistry (2001) 2.39
The therapeutic potential of modulating the ceramide/sphingomyelin pathway. J Clin Invest (2002) 2.30
S-adenosylmethionine in alcoholic liver cirrhosis: a randomized, placebo-controlled, double-blind, multicenter clinical trial. J Hepatol (1999) 2.14
S-adenosylmethionine synthesis: molecular mechanisms and clinical implications. Pharmacol Ther (1997) 2.13
Spontaneous oxidative stress and liver tumors in mice lacking methionine adenosyltransferase 1A. FASEB J (2002) 2.04
Enhanced tumour necrosis factor and interleukin-1 in fulminant hepatic failure. Lancet (1988) 1.82
Inhibition of matrix metalloproteinases blocks lethal hepatitis and apoptosis induced by tumor necrosis factor and allows safe antitumor therapy. Nat Med (2001) 1.81
Zn2+-stimulated sphingomyelinase is secreted by many cell types and is a product of the acid sphingomyelinase gene. J Biol Chem (1996) 1.78
Induction of tumor necrosis factor alpha production by human hepatocytes in chronic viral hepatitis. J Exp Med (1994) 1.66
Compartmentalized production of ceramide at the cell surface. J Biol Chem (1995) 1.63
Increased plasma tumor necrosis factor in severe alcoholic hepatitis. Ann Intern Med (1990) 1.60
Defective TNF-alpha-mediated hepatocellular apoptosis and liver damage in acidic sphingomyelinase knockout mice. J Clin Invest (2003) 1.58
AIP1 mediates TNF-alpha-induced ASK1 activation by facilitating dissociation of ASK1 from its inhibitor 14-3-3. J Clin Invest (2003) 1.52
Selective glutathione depletion of mitochondria by ethanol sensitizes hepatocytes to tumor necrosis factor. Gastroenterology (1998) 1.52
Feeding S-adenosyl-L-methionine attenuates both ethanol-induced depletion of mitochondrial glutathione and mitochondrial dysfunction in periportal and perivenous rat hepatocytes. Hepatology (1995) 1.35
Functional proteomics of nonalcoholic steatohepatitis: mitochondrial proteins as targets of S-adenosylmethionine. Proc Natl Acad Sci U S A (2003) 1.35
S-adenosyl-L-methionine synthetase and phospholipid methyltransferase are inhibited in human cirrhosis. Hepatology (1988) 1.31
Purification and comparison of two forms of S-adenosyl-L-methionine synthetase from rat liver. Eur J Biochem (1987) 1.24
S-adenosylmethionine and methylthioadenosine are antiapoptotic in cultured rat hepatocytes but proapoptotic in human hepatoma cells. Hepatology (2002) 1.24
Trafficking of ganglioside GD3 to mitochondria by tumor necrosis factor-alpha. J Biol Chem (2002) 1.24
Effects of S-adenosylmethionine on lipid peroxidation and liver fibrogenesis in carbon tetrachloride-induced cirrhosis. J Hepatol (1996) 1.15
Natural ceramide reverses Fas resistance of acid sphingomyelinase(-/-) hepatocytes. J Biol Chem (2000) 1.14
Fas-mediated apoptosis is modulated by intracellular glutathione in human T cells. Eur J Immunol (1996) 1.14
A conserved AU-rich element in the 3' untranslated region of bcl-2 mRNA is endowed with a destabilizing function that is involved in bcl-2 down-regulation during apoptosis. FASEB J (2000) 1.12
Cloning, expression, and functional characterization of the beta regulatory subunit of human methionine adenosyltransferase (MAT II). J Biol Chem (2000) 1.11
Involvement of FAN in TNF-induced apoptosis. J Clin Invest (2001) 1.08
Vesicular anthracycline accumulation in doxorubicin-selected U-937 cells: participation of lysosomes. Blood (1997) 1.07
Human placenta sphingomyelinase, an exogenous acidic pH-optimum sphingomyelinase, induces oxidative stress, glutathione depletion, and apoptosis in rat hepatocytes. Hepatology (2000) 1.07
Sphingomyelinase activity causes transbilayer lipid translocation in model and cell membranes. J Biol Chem (2003) 1.05
Role of an acidic compartment in tumor-necrosis-factor-alpha-induced production of ceramide, activation of caspase-3 and apoptosis. Eur J Biochem (1998) 1.04
Fas/CD95/Apo-I activates the acidic sphingomyelinase via caspases. Cell Death Differ (1998) 1.02
S-adenosylmethionine treatment prevents carbon tetrachloride-induced S-adenosylmethionine synthetase inactivation and attenuates liver injury. Hepatology (1992) 1.02
Role of acidic sphingomyelinase in Fas/CD95-mediated cell death. J Biol Chem (2000) 1.02
Cell autonomous apoptosis defects in acid sphingomyelinase knockout fibroblasts. J Biol Chem (2001) 0.99
Studies on compartmentation of S-adenosyl-L-methionine in Saccharomyces cerevisiae and isolated rat hepatocytes. Biochim Biophys Acta (1983) 0.98
Studies on ubiquinone. Demonstration of the total biosynthesis of ubiquinone-9 in rat liver mitochondria. J Biol Chem (1974) 0.97
TNF receptor death domain-associated proteins TRADD and FADD signal activation of acid sphingomyelinase. J Biol Chem (1998) 0.96
Regulation of cytochrome P450 2C11 (CYP2C11) gene expression by interleukin-1, sphingomyelin hydrolysis, and ceramides in rat hepatocytes. J Biol Chem (1995) 0.95
Acidic sphingomyelinase (ASM) is necessary for fas-induced GD3 ganglioside accumulation and efficient apoptosis of lymphoid cells. J Exp Med (1998) 0.94
CD95(Fas/APO-1) signals ceramide generation independent of the effector stage of apoptosis. J Biol Chem (2000) 0.93
Human acid sphingomyelinase. Eur J Biochem (2003) 0.93
Lysosomal sphingomyelinase is not solicited for apoptosis signaling. FASEB J (2000) 0.92
Regulatory properties of adenosine triphosphate-L-methionine S-adenosyltransferase of rat liver. Biochem J (1973) 0.92
S-Adenosylmethionine revisited: its essential role in the regulation of liver function. Alcohol (2002) 0.91
Glutathione dependence of caspase-8 activation at the death-inducing signaling complex. J Biol Chem (2001) 0.87
Site-directed mutagenesis of rat liver S-adenosylmethionine synthetase. Identification of a cysteine residue critical for the oligomeric state. Biochem J (1996) 0.87
Acid sphingomyelinase activation requires caspase-8 but not p53 nor reactive oxygen species during Fas-induced apoptosis in human glioma cells. Exp Cell Res (2002) 0.85
Short-chain ceramide regulates hepatic methionine adenosyltransferase expression. J Hepatol (2001) 0.77
Mitochondrial free cholesterol loading sensitizes to TNF- and Fas-mediated steatohepatitis. Cell Metab (2006) 3.95
Programmed cell senescence during mammalian embryonic development. Cell (2013) 2.78
Mitochondrial glutathione, a key survival antioxidant. Antioxid Redox Signal (2009) 2.28
Rapid determination of scopolamine in evidence of recreational and predatory use. Sci Justice (2013) 2.01
Critical role of tumor necrosis factor receptor 1, but not 2, in hepatic stellate cell proliferation, extracellular matrix remodeling, and liver fibrogenesis. Hepatology (2011) 1.73
Sensitivity of the 2-oxoglutarate carrier to alcohol intake contributes to mitochondrial glutathione depletion. Hepatology (2003) 1.72
ASMase is required for chronic alcohol induced hepatic endoplasmic reticulum stress and mitochondrial cholesterol loading. J Hepatol (2013) 1.61
Enhanced free cholesterol, SREBP-2 and StAR expression in human NASH. J Hepatol (2009) 1.60
Defective TNF-alpha-mediated hepatocellular apoptosis and liver damage in acidic sphingomyelinase knockout mice. J Clin Invest (2003) 1.58
Dual role of mitochondrial reactive oxygen species in hypoxia signaling: activation of nuclear factor-{kappa}B via c-SRC and oxidant-dependent cell death. Cancer Res (2007) 1.53
Targeting cholesterol at different levels in the mevalonate pathway protects fatty liver against ischemia-reperfusion injury. J Hepatol (2010) 1.51
Caveolin-1 deficiency causes cholesterol-dependent mitochondrial dysfunction and apoptotic susceptibility. Curr Biol (2011) 1.31
Mitochondrial cholesterol loading exacerbates amyloid beta peptide-induced inflammation and neurotoxicity. J Neurosci (2009) 1.27
Trafficking of ganglioside GD3 to mitochondria by tumor necrosis factor-alpha. J Biol Chem (2002) 1.24
Acidic sphingomyelinase controls hepatic stellate cell activation and in vivo liver fibrogenesis. Am J Pathol (2010) 1.24
Cathepsins B and D drive hepatic stellate cell proliferation and promote their fibrogenic potential. Hepatology (2009) 1.23
Specific contribution of methionine and choline in nutritional nonalcoholic steatohepatitis: impact on mitochondrial S-adenosyl-L-methionine and glutathione. J Biol Chem (2010) 1.22
Mitochondrial cholesterol contributes to chemotherapy resistance in hepatocellular carcinoma. Cancer Res (2008) 1.21
Critical role of acidic sphingomyelinase in murine hepatic ischemia-reperfusion injury. Hepatology (2006) 1.19
Reactive oxygen species mediate liver injury through parenchymal nuclear factor-kappaB inactivation in prolonged ischemia/reperfusion. Am J Pathol (2009) 1.15
Acetaldehyde impairs mitochondrial glutathione transport in HepG2 cells through endoplasmic reticulum stress. Gastroenterology (2003) 1.14
Sphingolipid signalling and liver diseases. Liver Int (2007) 1.13
RasGRF1 disruption causes retinal photoreception defects and associated transcriptomic alterations. J Neurochem (2009) 1.12
Redox control of liver function in health and disease. Antioxid Redox Signal (2010) 1.12
Mitochondrial glutathione: features, regulation and role in disease. Biochim Biophys Acta (2012) 1.11
Melanin precursors prevent premature age-related and noise-induced hearing loss in albino mice. Pigment Cell Melanoma Res (2009) 1.11
Critical role of mitochondrial glutathione in the survival of hepatocytes during hypoxia. J Biol Chem (2004) 1.10
Cathepsin B overexpression due to acid sphingomyelinase ablation promotes liver fibrosis in Niemann-Pick disease. J Biol Chem (2011) 1.07
Cholesterol impairs the adenine nucleotide translocator-mediated mitochondrial permeability transition through altered membrane fluidity. J Biol Chem (2003) 1.07
RNA microarray analysis in prenatal mouse cochlea reveals novel IGF-I target genes: implication of MEF2 and FOXM1 transcription factors. PLoS One (2010) 1.05
Statins and protein prenylation in cancer cell biology and therapy. Anticancer Agents Med Chem (2012) 1.05
Growth arrest-specific protein 6 is hepatoprotective against murine ischemia/reperfusion injury. Hepatology (2010) 1.05
Mechanism of mitochondrial glutathione-dependent hepatocellular susceptibility to TNF despite NF-kappaB activation. Gastroenterology (2008) 1.04
A network of growth and transcription factors controls neuronal differentation and survival in the developing ear. Int J Dev Biol (2007) 0.98
Glycosphingolipids and mitochondria: role in apoptosis and disease. Glycoconj J (2004) 0.98
Spatial and temporal segregation of auditory and vestibular neurons in the otic placode. Dev Biol (2008) 0.96
APP/PS1 mice overexpressing SREBP-2 exhibit combined Aβ accumulation and tau pathology underlying Alzheimer's disease. Hum Mol Genet (2013) 0.95
Cholesterol and peroxidized cardiolipin in mitochondrial membrane properties, permeabilization and cell death. Biochim Biophys Acta (2010) 0.95
Silencing human genetic diseases with oligonucleotide-based therapies. Hum Genet (2013) 0.95
Liver cell proliferation requires methionine adenosyltransferase 2A mRNA up-regulation. Hepatology (2002) 0.95
A comparative study of age-related hearing loss in wild type and insulin-like growth factor I deficient mice. Front Neuroanat (2010) 0.94
Hepatocarcinogenesis and ceramide/cholesterol metabolism. Anticancer Agents Med Chem (2012) 0.94
Ganglioside GD3 sensitizes human hepatoma cells to cancer therapy. J Biol Chem (2002) 0.93
AKT signaling mediates IGF-I survival actions on otic neural progenitors. PLoS One (2012) 0.92
Cochlear abnormalities in insulin-like growth factor-1 mouse mutants. Hear Res (2002) 0.92
S-Adenosyl-L-methionine and mitochondrial reduced glutathione depletion in alcoholic liver disease. Alcohol (2002) 0.91
RAF kinase activity regulates neuroepithelial cell proliferation and neuronal progenitor cell differentiation during early inner ear development. PLoS One (2010) 0.91
Cholesterol and sphingolipids in alcohol-induced liver injury. J Gastroenterol Hepatol (2008) 0.90
Serum deprivation increases ceramide levels and induces apoptosis in undifferentiated HN9.10e cells. Neurochem Int (2002) 0.90
Redox regulation of hepatocyte apoptosis. J Gastroenterol Hepatol (2007) 0.90
Ceramide, tumor necrosis factor and alcohol-induced liver disease. Alcohol Clin Exp Res (2005) 0.90